Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

NCT05904028 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

DRUG: Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
DEVICE: Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]
[object Object]